fda warning letters glp-1 compounded september 2025 Trends In FY FDA Takes Aim at Hims

CJC-1295 Without DAC (Modified GRF 1-29) Modified GRF (1-29) commonly referred to in research as CJC-1295 without DAC is a synthetic analogue of endogenous GHRH, representing a further-modified form of Sermorelin (GRF 1-29) with four strategic amino acid substitutions incorporated to prevent enzymatic degradation and oxidation, while increasing binding affinity to the GHRH receptor

Does adding cagrilintide to tirzepatide provide additional benefit

Be aware of safety issues and long-term unknowns

Kerr-German said its important to remember that correlation does not equal causation

An oxidized vitamin C is inert and the body just discards it

Defining the role of Parasutterella, a previously uncharacterized member of the core gut microbiota (in Eng)